Corporate Strategy Development

CHALLENGES: RAPIDLY CHANGING SOURCES OF BUSINESS VALUE

Most life science companies have a deep understanding of their core business and markets.  However, they face the following challenges:

• The rapid pace of technological and scientific advancement leaves even the most robust strategic planning process vulnerable to unforeseen threats.
• The lifespan of hard-earned market dominance can shrink rapidly and incremental corporate strategies based on extrapolations from the current situation are rarely accurate in the life science market.

SCIENTIA APPROACH: ALIGNING BUSINESS PORTFOLIO WITH CHANGING OPPORTUNITIES

We start with a corporate portfolio assessment and, upon the completion of the baseline information, we design a strategic plan aligning the firm’s portfolio with upcoming opportunities:

• Portfolio assessment: This phase begins with a detailed market and financial review of all the company’s assets. We then assess how well the client is performing relative to the industry's best practices and the marketplace's full potential.
• Strategic planning: This phase includes recommendations and advises as to where the client should focus. We jointly identify assets and technologies that could add more value, as well as targets for acquisition or divestiture.

SCIENTIA KNOW-HOW

We help all kinds and sizes of life science and healthcare companies craft, validate, and implement successful corporate strategies.  Our team is experienced in separating the hype from the truly game-changing trends, and grounding strategic assessments in reality.  Our tested collaborative process builds consensus among key stakeholders and consists of:

• Bringing validated market insights and thought leadership supported by primary research in the life sciences.
• Monitoring the dynamics forces shaping the life science markets to uncover and exploit opportunities.
• Testing assumptions against market data.

To learn more about Scientia’s Corporate Strategy Development capabilities, please contact us.